OpGen Stock (NASDAQ: OPGN) stock price, news, charts, stock research, profile.
Open | $2.69 |
Close | $2.75 |
Volume / Avg. | 3.21K / 32.03K |
Day Range | 2.66 - 2.75 |
52 Wk Range | 1.65 - 38.40 |
Market Cap | $3.36M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 4.13% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of OpGen (NASDAQ:OPGN) through any online brokerage.
Other companies in OpGen’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Alzamend Neuro (NASDAQ:ALZN), Entero Therapeutics (NASDAQ:ENTO), Synaptogenix (NASDAQ:SNPX) and NexImmune (NASDAQ:NEXI).
There is no analysis for OpGen.
OpGen has a consensus price target of $0.00.
The stock price for OpGen (NASDAQ: OPGN) is $2.5 last updated July 5, 2024 at 5:15 PM EDT.
There are no upcoming dividends for OpGen.
OpGen’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for OpGen.
OpGen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.